查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750816

基因治疗平台市场规模、份额、趋势分析报告（按平台类型、治疗应用、交付模式、最终用途、地区、细分市场预测，2025-2030 年）

Gene Therapy Platform Market Size, Share & Trends Analysis Report By Platform Type (Viral Vector Platforms, Non-Viral Vector Platforms), By Therapeutic Application, By Delivery Mode, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

基因治疗平台市场规模与趋势

预计 2024 年全球基因治疗平台市场价值将达到 21.4 亿美元，2025 年至 2030 年的复合年增长率将达到 15.2%。

这一增长将受到几个关键驱动因素的推动，包括快速的技术进步、遗传疾病和慢性病患病率的上升、生物製药研究的投资和资金筹措的增加，以及促进快速核准的支持性法规结构。

病毒载体技术、包括 CRISPR 在内的基因编辑工具、人工智慧整合以及製造自动化等技术创新正在提高治疗的精确度和生产效率。例如，Catalent 将于 2023 年 3 月增强其 UpTempo AAV 平台，以加速基因疗法的开发。

美国食品药物管理局 (FDA)核准的罕见疾病和遗传疾病的基因疗法数量不断增加，检验了这些平台的临床潜力，鼓励了投资和研发。例如，2023 年 12 月，基于 CRISPR 的治疗方法（例如 exagamglogene autotemcel (Casgevy)）获得 FDA核准，用于治疗镰状细胞疾病和 β-地中海贫血，标誌着基因治疗领域的一个重要里程碑。这些突破正在推动这一领域的发展，为一系列遗传疾病带来更有效率的治疗技术。

全球遗传疾病和慢性疾病的发病率不断上升，这推动了对分子层面标靶治疗的基因治疗需求。囊肿纤维化、血友病、脊髓性肌肉萎缩症以及各种癌症等疾病正越来越多地采用具有潜在治癒性的基因治疗方法进行治疗。世界卫生组织 (WHO) 预测，2024 年全球癌症患者数量将急剧增加，到 2050 年预计将新增超过 3,500 万例癌症病例。患者数量的增长带来了对先进疗法的迫切需求，刺激了对基因治疗技术的投资和创新，以满足尚未满足的医疗需求。

此外，对创新治疗方法的监管支持也推动了市场成长。美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等监管机构已经认识到基因疗法的变革潜力，并简化了其核准流程。此外，快速通道资格认定和孤儿药资格认定等监管激励措施也进一步支持了基因疗法的发展。这些措施有助于缩短开发时间，并加快引入能够满足未满足医疗需求的新治疗方法。

新冠疫情对市场造成了重大衝击，扰乱了临床试验、生产和供应链。新冠疫苗生产原料需求的增加导致原料短缺，影响了基因治疗生产所需关键成分的供应。儘管面临这些挑战，疫情也刺激了创新，一些基因治疗研发人员正在研发新冠相关的疗法和疫苗，凸显了基因治疗领域的韧性和潜力。

目录

第一章调查方法与范围

第二章执行摘要

3. 基因治疗平台市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业挑战与机会分析
  • 基因治疗平台市场分析工具
    • 波特分析
    • PESTEL分析
  • 法律规范
  • 新兴技术
  • COVID-19对基因治疗平台市场的影响
  • 使用案例和见解

第四章基因治疗平台市场：依平台类型估计与趋势分析

  • 定义和范围
  • 2024 年和 2030 年平台类型市场占有率分析
  • 细分仪表板
  • 2018-2030年基因治疗平台市场（依平台类型）
  • 病毒载体平台
    • 腺结合病毒（AAV）
    • 慢病毒
    • 逆转录病毒
    • 腺病毒
    • 单纯疱疹病毒（HSV）
  • 非病毒载体平台
    • 脂质奈米颗粒（LNP）
    • 电穿孔和显微注射平台
    • 基于聚合物的递送系统
    • 裸露DNA/RNA递送
  • 基因编辑平台
    • CRISPR-Cas系统
    • TALENs
    • ZFN

第五章基因治疗平台市场：按治疗应用的估计和趋势分析

  • 定义和范围
  • 2024 年及 2030 年治疗用途市场占有率分析
  • 细分仪表板
  • 2018-2030年基因治疗平台市场（依治疗应用）
  • 肿瘤学
  • 罕见遗传疾病
  • 心血管疾病
  • 神经系统疾病
  • 眼科疾病
  • 血液疾病（例如血友病、镰状细胞疾病）
  • 肌肉骨骼疾病
  • 感染疾病（例如爱滋病毒、新冠肺炎的辅助性治疗）

6. 基因治疗平台市场交付模式、估值及趋势分析

  • 定义和范围
  • 2024 年及 2030 年配送方式市场占有率分析
  • 细分仪表板
  • 2018-2030年基因治疗平台市场（依交付模式）
  • 体内基因治疗
  • 体外基因治疗
    • 自体细胞基因治疗
    • 同种异体细胞基因治疗
  • 其他（原位基因治疗）

第七章基因治疗平台市场：依最终用途的估计和趋势分析

  • 定义和范围
  • 2024 年及 2030 年最终用途市场占有率分析
  • 细分仪表板
  • 基因治疗平台市场（依最终用途划分），2018-2030
  • 製药和生物技术公司
  • 学术研究所
  • 合约开发和製造组织（CDMO）
  • 医院及基因治疗中心

8. 基因治疗平台市场：按平台类型、治疗应用、交付方式、最终用途和地区进行的估计和趋势分析

  • 定义和范围
  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 区域市场概况
  • SWOT分析
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 基因治疗平台市场占有率（按地区划分）（2024 年和 2030 年，百万美元）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 公司分类
  • 公司市场占有率分析
  • 公司热图分析
  • 公司简介
    • Lonza
    • BioIT
    • Autolomous Ltd
    • Hypertrust 病患资料照护（埃森哲旗下）
    • IBM
    • L7 Informatics, Inc.
    • TrakCel
    • IDBS
    • Novartis
    • SAP SE
    • DEEP GENOMICS
    • ElevateBio
    • Sarepta Therapeutics, Inc.
    • CRISPR Therapeutics
    • Precision BioSciences
    • AstraZeneca
    • Andelyn Biosciences
    • Renova Therapeutics
Product Code: GVR-4-68040-589-6

Gene Therapy Platform Market Size & Trends:

The global gene therapy platform market size was estimated at USD 2.14 billion in 2024 and is projected to grow at a CAGR of 15.2% from 2025 to 2030. The growth is driven by several key drivers, including rapid technological advancements, increasing prevalence of genetic and chronic diseases, growing investments and funding in biopharmaceutical research, and supportive regulatory frameworks facilitating faster approvals.

Innovations in viral vector technologies, gene editing tools including CRISPR, integration of AI and automation in manufacturing are enhancing therapy precision and production efficiency. For instance, in March 2023, Catalent is enhancing its UpTempo AAV platform to speed up the development of gene therapies.

The increasing number of FDA approvals for gene therapies targeting rare and genetic diseases has validated the clinical potential of these platforms, encouraging investment and R&D. For instance, in December 2023[, CRISPR-based therapies, like Exagamglogene autotemcel (Casgevy), received FDA approval for sickle cell disease and beta-thalassemia, marking a significant milestone in gene therapy. These breakthroughs are pushing the field forward, enabling more efficient technology for various genetic disorders.

The rising prevalence of genetic disorders and chronic diseases worldwide, is fueling demand for gene therapies that target disease at the molecular level. Conditions such as cystic fibrosis, hemophilia, spinal muscular atrophy, and various cancers are increasingly treated with gene therapy approaches that offer potentially curative outcomes. The World Health Organization (WHO) in 2024 projected a sharp increase in cancer cases globally, with over 35 million new cases expected by 2050, up 77% from 2022. This growing patient pool creates urgent demand for advanced treatments, driving investment and innovation in gene therapy technologies to address unmet medical needs.

Moreover, regulatory support for innovative therapies is driving market growth. Regulatory agencies, including the FDA and the European Medicines Agency (EMA), have streamlined approval processes for gene therapies, recognizing their transformative potential. In addition, regulatory incentives such as fast-track designations and orphan drug status further support the development of gene therapies. These measures help reduce development timelines and encourage the introduction of new treatments to address unmet medical needs.

The COVID-19 pandemic significantly impacted the market, disrupting clinical trials, manufacturing, and supply chains. The increased demand for raw materials for COVID-19 vaccine production caused shortages, affecting the availability of essential components for gene therapy manufacturing. Despite these challenges, the pandemic also spurred innovation, with some gene therapy developers adapting their efforts toward COVID-19-related therapeutics and vaccines, highlighting the resilience and potential of the gene therapy sector.

Global Gene Therapy Platform Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global gene therapy platform market report based on platform type, application, delivery method, end use, and region.

  • Platform Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Viral Vector Platforms
    • Adeno-associated Virus (AAV)
    • Lentivirus
    • Retrovirus
    • Adenovirus
    • Herpes Simplex Virus (HSV)
  • Non-Viral Vector Platforms
    • Lipid Nanoparticles (LNPs)
    • Electroporation & Microinjection Platforms
    • Polymer-based Delivery Systems
    • Naked DNA/RNA Delivery
  • Gene Editing Platforms
    • CRISPR-Cas Systems
    • TALENs
    • ZFNs
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology
  • Rare Genetic Disorders
  • Cardiovascular Diseases
  • Neurological Disorders
  • Ophthalmic Diseases
  • Hematological Disorders (e.g., Hemophilia, Sickle Cell)
  • Musculoskeletal Disorders
  • Infectious Diseases (e.g., HIV, COVID-19 adjunct therapies)
  • Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)
  • In Vivo Gene Therapy
  • Ex Vivo Gene Therapy
    • Autologous Cell-Based Gene Therapy
    • Allogeneic Cell-Based Gene Therapy
  • Others (In-situ Gene therapy)
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Hospitals & Gene Therapy Centers
  • Regional Outlook (Revenue, USD Million, 2018-2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Scope
    • 1.2.1. Platform Type
    • 1.2.2. Application
    • 1.2.3. Delivery Method
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Platform Type Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. Delivery Method Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Gene Therapy Platform Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising prevalence of genetic disorders
      • 3.2.1.2. Advancements in gene editing technologies
      • 3.2.1.3. Supportive regulatory frameworks
      • 3.2.1.4. Growing investment and strategic partnerships
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of development and treatment
    • 3.2.3. Industry Challenges and Opportunity Analysis
  • 3.3. Gene Therapy Platform Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
  • 3.4. Regulatory Framework
  • 3.5. Emerging Technologies
  • 3.6. Impact of COVID 19 on the Gene Therapy Platform Market
  • 3.7. Case Study & Insights

Chapter 4. Gene Therapy Platform Market: Platform Type Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Platform Type Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Gene Therapy Platform Market: By Platform Type, 2018 to 2030
  • 4.5. Viral Vector Platforms
    • 4.5.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Adeno-associated Virus (AAV)
      • 4.5.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Lentivirus
      • 4.5.3.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Retrovirus
      • 4.5.4.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Adenovirus
      • 4.5.5.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Herpes Simplex Virus (HSV)
      • 4.5.6.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Non-Viral Vector Platforms
    • 4.6.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Lipid Nanoparticles (LNPs)
      • 4.6.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Electroporation & Microinjection Platforms
      • 4.6.3.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Polymer-based Delivery Systems
      • 4.6.4.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Naked DNA/RNA Delivery
      • 4.6.5.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Gene Editing Platforms
    • 4.7.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. CRISPR-Cas Systems
      • 4.7.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. TALENs
      • 4.7.3.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.4. ZFNs
      • 4.7.4.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Gene Therapy Platform Market: Application Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Gene Therapy Platform Market: By Application, 2018 to 2030
  • 5.5. Oncology
    • 5.5.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Rare Genetic Disorders
    • 5.6.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Cardiovascular Diseases
    • 5.7.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Neurological Disorders
    • 5.8.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Ophthalmic Diseases
    • 5.9.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Hematological Disorders (e.g., Hemophilia, Sickle Cell)
    • 5.10.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Musculoskeletal Disorders
    • 5.11.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.12. Infectious Diseases (e.g., HIV, COVID-19 adjunct therapies)
    • 5.12.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Gene Therapy Platform Market: Delivery Method Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Delivery Mode Market Share Analysis, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Gene Therapy Platform Market: By Delivery Mode, 2018 to 2030
  • 6.5. In Vivo Gene Therapy
    • 6.5.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Ex Vivo Gene Therapy
    • 6.6.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Autologous Cell-Based Gene Therapy
      • 6.6.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Allogeneic Cell-Based Gene Therapy
      • 6.6.3.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others (In-situ Gene therapy)
    • 6.7.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Gene Therapy Platform Market: End Use Estimates & Trend Analysis

  • 7.1. Definition and Scope
  • 7.2. End Use Market Share Analysis, 2024 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Gene Therapy Platform Market: By End Use, 2018 to 2030
  • 7.5. Pharmaceutical & Biotechnology Companies
    • 7.5.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Academic & Research Institutions
    • 7.6.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Contract Development & Manufacturing Organizations (CDMOs)
    • 7.7.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Hospitals & Gene Therapy Centers
    • 7.8.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Gene Therapy Platform Market: Regional Estimates & Trend Analysis by Platform Type, Therapeutic Application, Delivery Method, and End Use

  • 8.1. Definition and Scope
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. SWOT Analysis
    • 8.5.1. North America
    • 8.5.2. Europe
    • 8.5.3. Asia Pacific
    • 8.5.4. Latin America
    • 8.5.5. Middle East & Africa
  • 8.6. Gene Therapy Platform Market Share, By Region, 2024 & 2030, USD Million
  • 8.7. North America
    • 8.7.1. North America Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. U.S.
      • 8.7.2.1. U.S. Key Country Dynamics
      • 8.7.2.2. Regulatory Landscape
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. U.S. Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Canada
      • 8.7.3.1. Canada Key Country Dynamics
      • 8.7.3.2. Regulatory Landscape
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Canada Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. Mexico
      • 8.7.4.1. Mexico Key Country Dynamics
      • 8.7.4.2. Regulatory Landscape
      • 8.7.4.3. Competitive Insights
      • 8.7.4.4. Mexico Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Europe
    • 8.8.1. Europe Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. UK
      • 8.8.2.1. UK Key Country Dynamics
      • 8.8.2.2. Regulatory Landscape
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. U.K. Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Germany
      • 8.8.3.1. Germany Key Country Dynamics
      • 8.8.3.2. Regulatory Landscape
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Germany Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. France
      • 8.8.4.1. France Key Country Dynamics
      • 8.8.4.2. Regulatory Landscape
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. France Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Italy
      • 8.8.5.1. Italy Key Country Dynamics
      • 8.8.5.2. Regulatory Landscape
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Italy Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.6. Spain
      • 8.8.6.1. Spain Key Country Dynamics
      • 8.8.6.2. Regulatory Landscape
      • 8.8.6.3. Competitive Insights
      • 8.8.6.4. Spain Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.7. Sweden
      • 8.8.7.1. Sweden Key Country Dynamics
      • 8.8.7.2. Regulatory Landscape
      • 8.8.7.3. Competitive Insights
      • 8.8.7.4. Sweden Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.8. Denmark
      • 8.8.8.1. Denmark Key Country Dynamics
      • 8.8.8.2. Regulatory Landscape
      • 8.8.8.3. Competitive Insights
      • 8.8.8.4. Denmark Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.9. Norway
      • 8.8.9.1. Norway Key Country Dynamics
      • 8.8.9.2. Regulatory Landscape
      • 8.8.9.3. Competitive Insights
      • 8.8.9.4. Norway Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9. Asia Pacific
    • 8.9.1. Asia Pacific Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.2. China
      • 8.9.2.1. China Key Country Dynamics
      • 8.9.2.2. Regulatory Landscape
      • 8.9.2.3. Competitive Insights
      • 8.9.2.4. China Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.3. Japan
      • 8.9.3.1. Japan Key Country Dynamics
      • 8.9.3.2. Regulatory Landscape
      • 8.9.3.3. Competitive Insights
      • 8.9.3.4. Japan Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.4. India
      • 8.9.4.1. India Key Country Dynamics
      • 8.9.4.2. Regulatory Landscape
      • 8.9.4.3. Competitive Insights
      • 8.9.4.4. India Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.5. South Korea
      • 8.9.5.1. South Korea Key Country Dynamics
      • 8.9.5.2. Regulatory Landscape
      • 8.9.5.3. Competitive Insights
      • 8.9.5.4. South Korea Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.6. Australia
      • 8.9.6.1. Australia Key Country Dynamics
      • 8.9.6.2. Regulatory Landscape
      • 8.9.6.3. Competitive Insights
      • 8.9.6.4. Australia Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.7. Thailand
      • 8.9.7.1. Thailand Key Country Dynamics
      • 8.9.7.2. Regulatory Landscape
      • 8.9.7.3. Competitive Insights
      • 8.9.7.4. Thailand Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.10. Latin America
    • 8.10.1. Latin America Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.10.2. Brazil
      • 8.10.2.1. Brazil Key Country Dynamics
      • 8.10.2.2. Regulatory Landscape
      • 8.10.2.3. Competitive Insights
      • 8.10.2.4. Brazil Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.10.3. Argentina
      • 8.10.3.1. Argentina Key Country Dynamics
      • 8.10.3.2. Regulatory Landscape
      • 8.10.3.3. Competitive Insights
      • 8.10.3.4. Argentina Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11. Middle East and Africa
    • 8.11.1. Middle East and Africa Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.2. South Africa
      • 8.11.2.1. South Africa Key Country Dynamics
      • 8.11.2.2. Regulatory Landscape
      • 8.11.2.3. Competitive Insights
      • 8.11.2.4. South Africa Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.3. Saudi Arabia
      • 8.11.3.1. Saudi Arabia Key Country Dynamics
      • 8.11.3.2. Regulatory Landscape
      • 8.11.3.3. Competitive Insights
      • 8.11.3.4. Saudi Arabia Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.4. UAE
      • 8.11.4.1. UAE Key Country Dynamics
      • 8.11.4.2. Regulatory Landscape
      • 8.11.4.3. Competitive Insights
      • 8.11.4.4. UAE Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.5. Kuwait
      • 8.11.5.1. Kuwait Key Country Dynamics
      • 8.11.5.2. Regulatory Landscape
      • 8.11.5.3. Competitive Insights
      • 8.11.5.4. Kuwait Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Company Market Share Analysis
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Lonza
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments
    • 9.4.2. BioIT
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments
    • 9.4.3. Autolomous Ltd
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments
    • 9.4.4. Hypertrust Patient Data Care (Part of Accenture)
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments
    • 9.4.5. IBM
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments
    • 9.4.6. L7 Informatics, Inc.
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments
    • 9.4.7. TrakCel
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments
    • 9.4.8. IDBS
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments
    • 9.4.9. Novartis
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments
    • 9.4.10. SAP SE
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments
    • 9.4.11. DEEP GENOMICS
      • 9.4.11.1. Participant's Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Recent Developments
    • 9.4.12. ElevateBio
      • 9.4.12.1. Participant's Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Recent Developments
    • 9.4.13. Sarepta Therapeutics, Inc.
      • 9.4.13.1. Participant's Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Product Benchmarking
      • 9.4.13.4. Recent Developments
    • 9.4.14. CRISPR Therapeutics
      • 9.4.14.1. Participant's Overview
      • 9.4.14.2. Financial Performance
      • 9.4.14.3. Product Benchmarking
      • 9.4.14.4. Recent Developments
    • 9.4.15. Precision BioSciences
      • 9.4.15.1. Participant's Overview
      • 9.4.15.2. Financial Performance
      • 9.4.15.3. Product Benchmarking
      • 9.4.15.4. Recent Developments
    • 9.4.16. AstraZeneca
      • 9.4.16.1. Participant's Overview
      • 9.4.16.2. Financial Performance
      • 9.4.16.3. Product Benchmarking
      • 9.4.16.4. Recent Developments
    • 9.4.17. Andelyn Biosciences
      • 9.4.17.1. Participant's Overview
      • 9.4.17.2. Financial Performance
      • 9.4.17.3. Product Benchmarking
      • 9.4.17.4. Recent Developments
    • 9.4.18. Renova Therapeutics
      • 9.4.18.1. Participant's Overview
      • 9.4.18.2. Financial Performance
      • 9.4.18.3. Product Benchmarking
      • 9.4.18.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 4 North America gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 5 North America gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 6 North America gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 8 U.S. gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 10 U.S. gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 12 Canada gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 13 Canada gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 14 Canada gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 15 Mexico gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 16 Mexico gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 17 Mexico gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 18 Mexico gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 20 Europe gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 21 Europe gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 22 Europe gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 23 UK gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 24 UK gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 25 UK gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 26 UK gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 28 Germany gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 29 Germany gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 30 Germany gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 31 France gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 32 France gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 33 France gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 34 France gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 35 Italy gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 36 Italy gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 37 Italy gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 38 Italy gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 39 Spain gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 40 Spain gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 41 Spain gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 42 Spain gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 43 Sweden gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 44 Sweden gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 45 Sweden gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 46 Sweden gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 47 Denmark gene therapy platform market estimates and forecasts by platform type, 2018 - 2030 (USD Million)
  • Table 48 Denmark gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 49 Denmark gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 50 Denmark gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 51 Norway gene therapy platform market estimates and forecasts by platform type, 2018 - 2030 (USD Million)
  • Table 52 Norway gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 53 Norway gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 54 Norway gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific gene therapy platform market estimates and forecasts by platform type, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 59 Japan gene therapy platform market estimates and forecasts by platform type, 2018 - 2030 (USD Million)
  • Table 60 Japan gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 61 Japan gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 62 Japan gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 63 China gene therapy platform market estimates and forecasts by platform type, 2018 - 2030 (USD Million)
  • Table 64 China gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 65 China gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 66 China gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 67 India gene therapy platform market estimates and forecasts by platform type, 2018 - 2030 (USD Million)
  • Table 68 India gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 69 India gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 70 India gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 71 Australia gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 72 Australia gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 73 Australia gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 74 Australia gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 75 South Korea gene therapy platform market estimates and forecasts by platform type, 2018 - 2030 (USD Million)
  • Table 76 South Korea gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 77 South Korea gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 78 South Korea gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 79 Thailand gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 80 Thailand gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 81 Thailand gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 82 Thailand gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 83 Latin America gene therapy platform market estimates and forecasts by platform type, 2018 - 2030 (USD Million)
  • Table 84 Latin America gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 85 Latin America gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 86 Latin America gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 87 Brazil gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 88 Brazil gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 89 Brazil gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 90 Brazil gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 91 Argentina gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 92 Argentina gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 93 Argentina gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 94 Argentina gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 95 MEA gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 96 MEA gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 97 MEA gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 98 MEA gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 99 South Africa gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 100 South Africa gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 101 South Africa gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 102 South Africa gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 103 Saudi Arabia gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 104 Saudi Arabia gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 105 Saudi Arabia gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 107 UAE gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 108 UAE gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 109 UAE gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 110 UAE gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 111 Kuwait gene therapy platform market estimates and forecasts, by platform type, 2018 - 2030 (USD Million)
  • Table 112 Kuwait gene therapy platform market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 113 Kuwait gene therapy platform market estimates and forecasts by delivery method, 2018 - 2030 (USD Million)
  • Table 114 Kuwait gene therapy platform market estimates and forecasts by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Gene Therapy Platform Market Segmentation
  • Fig. 2 Information Procurement
  • Fig. 3 Data Analysis Models
  • Fig. 4 Market Formulation and Validation
  • Fig. 5 Data Validating & Publishing
  • Fig. 6 Market Snapshot
  • Fig. 7 Segment Snapshot
  • Fig. 8 Competitive Landscape Snapshot
  • Fig. 9 Gene Therapy Platform- Market Size and Growth Prospects (USD Million)
  • Fig. 10 Gene Therapy Platform Market: Industry Value Chain Analysis
  • Fig. 11 Gene Therapy Platform Market: Market Dynamics
  • Fig. 12 Gene Therapy Platform Market: PORTER's Analysis
  • Fig. 13 Gene Therapy Platform Market: PESTEL Analysis
  • Fig. 14 Gene Therapy Platform Market, by Platform Type: Key Takeaways
  • Fig. 15 Gene Therapy Platform Market, by Platform Type: Market Share, 2024 & 2030
  • Fig. 16 Viral Vector Platforms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 17 Adeno-associated Virus (AAV) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 18 Lentivirus Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Retrovirus Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Adenovirus Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 21 Herpes Simplex Virus (HSV) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 22 Non-Viral Vector Platforms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 23 Lipid Nanoparticles (LNPs) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 24 Electroporation & Microinjection Platforms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 25 Polymer-based Delivery Systems Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 26 Naked DNA/RNA Delivery Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 27 Gene Editing Platforms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 28 CRISPR-Cas Systems Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 29 TALENs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 30 ZFNs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 31 Gene Therapy Platform Market, by Application: Key Takeaways
  • Fig. 32 Gene Therapy Platform Market, by Application: Market Share, 2024 & 2030
  • Fig. 33 Oncology Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 34 Rare Genetic Disorders Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 35 Cardiovascular Diseases Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 36 Neurological Disorders Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 37 Ophthalmic Diseases Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 38 Hematological Disorders (e.g., Hemophilia, Sickle Cell) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 39 Musculoskeletal Disorders Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 40 Infectious Diseases (e.g., HIV, COVID-19 adjunct therapies) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 41 Gene Therapy Platform Market, by Delivery Method: Key Takeaways
  • Fig. 42 Gene Therapy Platform Market, by Delivery Method: Market Share, 2024 & 2030
  • Fig. 43 In Vivo Gene Therapy Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 44 Ex Vivo Gene Therapy Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 45 Autologous Cell-Based Gene Therapy Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 46 Allogeneic Cell-Based Gene Therapy Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 47 Others (In-situ Gene therapy) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 48 Gene Therapy Platform Market, by End Use: Key Takeaways
  • Fig. 49 Gene Therapy Platform Market, by End Use: Market Share, 2024 & 2030
  • Fig. 50 Pharmaceutical & Biotechnology Companies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 51 Academic & Research Institutions Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 52 Contract Development & Manufacturing Organizations (CDMOs) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 53 Hospitals & Gene Therapy Centers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 54 Gene Therapy Platform Market Revenue, by Region, 2024 & 2030 (USD Million)
  • Fig. 55 Regional Marketplace: Key Takeaways
  • Fig. 56 Regional Marketplace: Key Takeaways
  • Fig. 57 North America Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 U.S. Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Canada Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Europe Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 UK Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Germany Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 France Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Italy Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Spain Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Sweden Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Denmark Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Norway Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Asia Pacific Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Japan Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 China Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 India Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Australia Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Latin America Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Brazil Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Argentina Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 MEA Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Saudi Arabia Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 UAE Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 South Africa Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Kuwait Gene Therapy Platform Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key Company Categorization
  • Fig. 85 Company Market Positioning
  • Fig. 86 Key Company Market Share Analysis, 2024
  • Fig. 87 Strategic Framework